Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Vues
• 07/10/23
0
0
Intégrer
administrator
Les abonnés
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires